Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.68 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 7/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 7/20 | 0.49 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 6/20 | 0.49 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6440917 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL9876090 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL6445380 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL6440597 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL6441961 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL3820923 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL6448034 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL6445532 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL5606003 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR | |
| SCHEMBL9875102 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2GABBR2CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131748-A1 | PYROTECHNIC CIRCUIT BREAKER COMPRISING A POLYMER COMPOSITION BASED ON A POLYPHTALAMIDE | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| CN-111201197-B | Aluminum phosphites and compositions comprising aluminum phosphites | 太平化学产业株式会社 | 2023-05-02 | — | — | CN | claimed |
| US-4136154-A | OXIDATION RESISTANCE, ZINC, ALUMINUM, OR CALCIUM SALT OF A PHOSPHINIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | claimed |
| US-12534597-B2 | Polyamide resin composition and molded object thereof | KURARAY CO., LTD. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-3696141-B1 | ALUMINIUM PHOSPHITE AND COMPOSITION CONTAINING ALUMINIUM PHOSPHITE | TAIHEI CHEM (JP) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025131748-A1 | PYROTECHNIC CIRCUIT BREAKER COMPRISING A POLYMER COMPOSITION BASED ON A POLYPHTALAMIDE | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-115443309-B | Colored polyamide resin composition and molded article thereof | 株式会社可乐丽 | 2024-10-29 | — | — | CN | disclosed |
| CN-114761478-B | Polyamide resin composition and molded article thereof | 株式会社可乐丽 | 2024-08-13 | — | — | CN | disclosed |
| US-20240182685-A1 | POLYAMIDE COMPOSITIONS | ENVALIOR DEUTSCHLAND GMBH (DE) | 2024-06-06 | — | — | US | disclosed |
| EP-4314140-A1 | POLYAMIDE COMPOSITIONS | LANXESS Deutschland GmbH (DE) | 2024-02-07 | — | — | EP | disclosed |
| CN-117441219-A | Electrolyte for electrolytic capacitor, electrolytic capacitor using the same, and hybrid electrolytic capacitor | 三洋化成工业株式会社 | 2024-01-23 | — | — | CN | disclosed |
| US-4220610-A | Organic phosphorus compounds with 2-hydroxyalkyl-phosphonic acid groups | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-09-02 | — | — | US | disclosed |
| EP-0009706-A1 | Organic phosphorus compounds containing 3-hydroxyalkylphosphinic acid ester groups, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-04-16 | — | — | EP | disclosed |
| EP-0003599-A1 | Organic phosphorus compounds with 2-hydroxyalkylphosphoric acid groups, process for their preparation and their use as flame retardants | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-08-22 | — | — | EP | disclosed |
| US-4136154-A | OXIDATION RESISTANCE, ZINC, ALUMINUM, OR CALCIUM SALT OF A PHOSPHINIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| EP-0000024-A1 | Polyadducts containing phosphorus and their application in the flameproofing of textile materials | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-12-20 | — | — | EP | disclosed |
| US-4078016-A | Halogenated aromatic polymer/metal phosphinate polymer flame retardant composition | CELANESE CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
| US-4069245-A | Preparation of phosphonic and/or phosphinic acids | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-01-17 | — | — | US | disclosed |
| US-4069247-A | Preparation of phosphonic and/or phosphinic acids | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-01-17 | — | — | US | disclosed |
| US-4016222-A | Unsaturated phosphorus compounds | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534597-B2 | Polyamide resin composition and molded object thereof | SMC2, DAP3, RPTOR | LPAR3 1406/4885LPAR2 652/4885GABBR2 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.